Title:
Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study)
Phase:
III
Contact:
Linda Lepczynski / Study Nurse
Email-Address:
Linda.Lepczynski@med.uni-heidelberg.de
Clinical Investigator:
PD Dr. med. Simon Raffel
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT04994717
EudraCT-Number:
Keine Registernummer angegeben.